DUBLIN, Dec. 7, 2023 /PRNewswire/ — The “Losmapimod Emerging Drug Insight and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about losmapimod for Facioscapulohumeral Muscular Dystrophy (FSHD) in the seven…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.